Mawdsleys secures compassionate access for critically ill patient

Mawdsleys secures compassionate access for critically ill patient 12th June 2025

We are extremely proud of our patient-centric unrivalled service at Mawdsleys.

Over a recent bank holiday, our unlicensed team received an urgent, time-sensitive order request from a leading NHS children’s hospital in the North West to secure compassionate access to a medicine on clinical trial in North America for a critically ill patient. The team ably navigated the regulatory complexities of importing a new medication, the entire process of sourcing the medicine to delivery took just 6 working days and crucially, we got the medicine to the patient quickly and safely.

The hospital thanked us for our “outstanding responses, knowledge, support and persistence”.

If you would like to learn more about how we can support you with your patients’ needs please get in touch today – info@mawdsleys.co.uk

Other latest news

Morningside Pharmaceuticals add Mawdsleys as a distributor to Hospitals

Mawdsleys is delighted to now be partnering with Morningside Pharmaceuticals as an additional distributor to supply their contract and non-contract products to hospitals. Morningside has a portfolio of 242 generic and branded licensed medicines in the UK and EU and is a proud manufacturer and supplier to NHS Trusts,…

Mawdsleys announces new solus deal with M&A Pharmachem

Mawdsleys is delighted to announce a new solus hospital distribution agreement with M&A Pharmachem. From 1st July 2014, Mawdsleys will become the sole distributor for all M&A Pharmachem contracted products into the hospital sector, which previously hospitals purchased from M&A directly. As from this date, all orders for M&A products…